In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
- Ocio, E.M.
- Vilanova, D.
- Atadja, P.
- Maiso, P.
- Crusoe, E.
- Fernández-Lázaro, D.
- Garayoa, M.
- San-Segundo, L.
- Hernández-Iglesias, T.
- de Álava, E.
- Shao, W.
- Yao, Y.-M.
- Pandiella, A.
- San-Miguel, J.F.
ISSN: 0390-6078, 1592-8721
Year of publication: 2010
Volume: 95
Issue: 5
Pages: 794-803
Type: Article